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ABSTRACT
Background and objective: Bronchiectasis manifests as
recurrent respiratory infections and reduced lung func-
tion. Airway dilation, which is measured as the ratio of
the diameters of the bronchial lumen (B) and adjacent
pulmonary artery (A), is a defining radiological feature
of bronchiectasis. A challenge to equating the bronch-
oarterial (BA) ratio to disease severity is that the dia-
meters of airway and vessel in health are not
established. We sought to explore the variability of BA
ratio in never-smokers without pulmonary disease and
its associations with lung function.
Methods: Objective measurements of the BA ratio on
volumetric computed tomography (CT) scans and pul-
monary function data were collected in 106 never-smo-
kers. The BA ratio was measured in the right upper lobe
apical bronchus (RB1) and the right lower lobe basal
posterior bronchus. The association between the BA
ratio and forced expiratory volume in 1 s (FEV1) was
assessed using regression analysis.
Results: The BA ratio was 0.79  0.16 and was smaller
in more peripheral RB1 bronchi (P < 0.0001). The BA
ratio was >1, a typical threshold for bronchiectasis, in
10 (8.5%) subjects. Subjects with a BA ratio >1 versus ≤1
had smaller artery diameters (P < 0.0001) but not sig-
nificantly larger bronchial lumens. After adjusting for
age, gender, race and height, the BA ratio was directly
related to FEV1 (P = 0.0007).
Conclusion: In never-smokers, the BA ratio varies by
airway generation and is associated with lung function.
A BA ratio >1 is driven by small arteries. Using artery
diameter as reference to define bronchial dilation
seems inappropriate.
Clinical trial registration: NCT00608764 at ClinicalTrials.gov
Key words: bronchiectasis, bronchoarterial ratio, non-smok-
ing, normal, volumetric computed tomography.
Abbreviations: BA, bronchoarterial; CCC, concordance
correlation coefficient; COPD, chronic obstructive pulmonary
disease; CT, computed tomography; FEV1, forced expiratory
volume in 1 s; FVC, forced vital capacity; i.v., intravenous; RB1,
right upper lobe apical bronchus; RB10, right lower lobe basal
posterior bronchus; TLC, total lung capacity; TLCCT, CT lung
volume at maximal inflation.
INTRODUCTION
Bronchiectasis is an important cause of morbidity in
the US population with a hospitalization rate of 16.5
per 100 000 population and the burden of the disease
is greater in older individuals.1 The clinical manifesta-
tions of bronchiectasis include productive cough,
recurrent infections and lung function impairment.2
The current gold standard to diagnose bronchiectasis is
visual inspection on thoracic computed tomography
(CT) scans.2 A defining radiographical feature is an
increased bronchial lumen diameter relative to the
adjacent pulmonary artery diameter, the bronchoarter-
ial (BA) ratio.3,4 A BA ratio >1 is typically considered
discriminatory for the presence of disease.2 A challenge
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SUMMARY AT A GLANCE
In 106 never-smokers adults, the mean ratio of the
diameters of the bronchial lumen and adjacent pul-
monary artery, a defining radiological feature of
bronchiectasis, was 0.79, varied by airway genera-
tion and in 8.5% of them was >1. This metric was
directly related with expiratory airflow regardless of
body size.
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of the BA ratio is that there are scarce data on its varia-
bility in never-smokers, and its potential association
with lung function has not been extensively explored.
A few CT studies have provided data on the BA ratio
in normal subjects with a mean ranging from 0.62 to
0.695.5–8 Interpretability of these data are limited due to
inconsistencies in the measurement techniques such as
using the outer bronchial diameter instead of the inner
luminal diameter to assess airway size. A second limita-
tion was the lack of exploration of relationships
between the bronchovascular structure and spirometric
measures of lung function. Also, sample sizes of non-
smoking subjects were small.5–7 It is known that sub-
jects with bronchiectasis have lung function
impairment,9–11 and thus exploring bronchovascular
structure–lung function relationships in never-smokers
subjects without clinical pulmonary disease might be
relevant to understand whether intrinsic lung structure
has implications for disease. Therefore, we hypothesize
that the BA ratio is related to expiratory airflow in
never-smokers. We also sought to explore the variabil-
ity of this imaging metric in this population.
METHODS
Subject selection
We used data from a cohort of 108 never-smokers
enrolled into the COPD gene (COPDGene) Study (data
set “Final10000_Dataset_12MAR13”).12 Briefly, this
study was designed to determine the genetic and epi-
demiological determinants of COPD in non-Hispanic
White and African-American smokers aged
45–80 years. The control population of COPDGene was
recruited based on an eligibility questionnaire and pul-
monary function data.13 Participants were considered
non-smoking controls if they responded No to the fol-
lowing questions: ‘Have you ever smoked cigarettes?’,
‘Have you ever been told by a physician that you had a
lung disease?’ and ‘Have you ever had lung surgery?’
In addition, these subjects had to meet a ratio of forced
expiratory volume in 1 s (FEV1) to forced vital capacity
(FVC) of ≥0.7. Never-smoker controls were enrolled in
different clinical sites across the USA with the majority
of them (n = 68) in two centres (University of Iowa and
Brigham and Women’s Hospital). The COPDGene
study was approved by the institutional review board at
each participating clinical centre, and all subjects pro-
vided written informed consent. The Partners Health-
Care Research Committee (2007P-000554) approved
this study.
Clinical and physiological assessments
Demographic and clinical data with standardized ques-
tionnaires including a modified adult respiratory ques-
tionnaire were collected.12 Spirometric measures of
lung function were performed before and after the
administration of albuterol according to American Tho-
racic Society recommendations. Post-bronchodilator
FEV1 and FVC were used for analysis. The two latter
spirometric measures of lung function were expressed
as percent of predicted values.14 Total lung capacity
(TLC) was measured using CT scan.15
CT analysis
All subjects underwent volumetric CT scanning with-
out i.v. contrast in the supine position at coached full
inspiration and relaxed exhalation; analyses in this
study focused on the inspiratory CT scans. Acquisition
parameters were the following: 120 kVp, 200 mAs and
0.5 rotation time. Images were reconstructed as fol-
lows: standard, B31f and B kernel; 0.625, 0.75 and
0.90 mm slice thickness; and 0.625, 0.5, and 0.45 mm
slice interval for General Electric Medical System
(General Electric Healthcare Chicago, IL), Siemens
(Siemens Healthineers, Erlangen, Germany) and Phi-
lips scanners (Philips Healthcare Denver, CO), respec-
tively.16 After segmenting the lung to exclude vessels
and airways, CT lung volume was calculated by multi-
plying the voxel volume by the number of voxels. CT
lung volume at maximal inflation approximates TLC
(TLCCT). TLCCT is expressed as percent of predicted
values.17
BA ratio measurements
A single trained analyst, a laboratory technician, with
3 years of experience in lung imaging performed the
BA ratio measurements on inspiratory CT scans using
Slicer software developed at Brigham and Women's
Hospital (Boston, MA) (www.slicer.org). Workstation
screen was set at window width of 1500 and window
level −450.6 CT measures of BA ratio were collected
based on anatomical locations in two bronchial paths:
in the right upper lobe apical bronchus (RB1) and the
right lower lobe basal posterior bronchus (RB10). We
chose these bronchial paths because the airway
branches are usually orthogonal to the axial plane,
which facilitates accurate measurement in both bron-
chi and pulmonary artery branches.18 We chose to per-
form manual, instead of automated measures, to
compare with prior research in this area. The airway
and pulmonary artery branches to be measured in a
given generation were selected based on their rounded
appearance on the axial plane. The analyst first identi-
fied RB1 and RB10 using all the three image planes as
needed and then performed two measurements in the
middle portion of one bronchial branch of the fourth,
fifth and sixth generations and its closest correspond-
ing artery branch. For the purpose of this investigation,
the first segment of RB1 and RB10 is designed as third
airway generation. A ruler within Slicer was used to
measure the airway lumen (inner edge to inner edge)
and artery diameters at both the longest and shortest
axes. Because a vein and artery close to an airway
might look similar on non-contrast CT scans, the ana-
lyst distinguished them by tracing back the vessel to
the central pulmonary artery. The BA ratios were com-
puted using the diameters of both axes and averaged
for each generation and bronchial path, and for both
RB1 and RB10. The latter was used for correlative
investigation. The analyst made a second set of the
above-mentioned measurements in 20 randomly
selected subjects to assess the intra-analyst reproduci-
bility. A second trained analyst took these measure-
ments in the same 20 subjects to assess the inter-
analyst reproducibility.
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Statistical analysis
Measurements are presented as mean  SD. Unless
otherwise noted, the ‘BA ratio’ is referred as the mean
BA ratio for RB1 and RB10. Intra- and inter-analyst
reproducibility assessment of the BA ratio was per-
formed using concordance correlation coefficient
(CCC) and Bland–Altman analysis.19,20 Differences
between subjects with the BA ratio >1 versus ≤1 were
performed with Wilcoxon sum rank test. Differences in
the BA ratio by airway generation and between RB1
and RB10 were tested with mixed models to account
for within-subject correlation in these metrics. Univari-
ate relationships between mean BA ratio and demo-
graphic data and spirometric measures of lung
function were tested using Pearson correlation coeffi-
cients. Multivariable regression analysis was used to
assess the association between FEV1 and the BA ratio.
Age, gender, race and a measure of body size, height,
were used as covariates. These four covariates were
chosen because they are the main determinants of
expiratory airflow in normal subjects.14 Analysis was
performed with SAS 9.4 (SAS Institute, Cary, NC, USA).
A P-value <0.05 was considered significant.
RESULTS
Subject characteristics
Among the 108 never-smokers subjects, two were
excluded because they had interstitial lung abnormal-
ities leaving a sample size of 106 subjects. Subjects’
characteristics are shown in Table 1. Their mean age
was 62 years and the majority were females (n = 72)
and non-Hispanic White (n = 98). FEV1, FVC and TLC
was 97% of predicted values or higher.
Intra- and inter-analyst reproducibility
The intra- and inter-analyst CCC for BA ratio was 0.80
(95% CI: 0.63–0.98) and 0.77 (0.61–0.92), respectively.
The Bland–Altman analysis showed no intra-analyst
systematic bias across the range of BA ratio values
(Fig. 1A). The plot for the inter-analyst agreement
shows a trend of increasing differences in BA ratio as
the mean measure between readers increases (r = 0.56,
P = 0.03) (Fig. 1B).
BA measurements
The mean BA ratio was 0.79  0.16 and varied by gen-
eration decreasing significantly in more peripheral air-
way generations (0.86 at fourth to 0.76 at sixth
generation, P = 0.0001) of RB1 (Table 2). This trend in
BA ratio was not observed in RB10. In 10 (8.5%) sub-
jects, the BA ratio was >1, a usual cut-off point to
define bronchiectasis. Subjects with a ratio >1 versus
≤1 had higher FEV1 (3.2  0.6 vs 2.8  0.7, P = 0.049)
with no differences in age (P = 0.36) or
height (P = 0.59).
To explore the relative contribution of bronchial and
vessel size to the BA ratio, we explored the differences
in mean airway lumen and mean artery diameters
between never-smokers with the BA ratio >1 versus ≤1.
The difference between these two groups was greater
and significant for the artery diameter (difference,
1 mm; P < 0.0001) than for the bronchial lumen diam-
eter (difference 0.35 mm; P = 0.09) (Fig. 2).
Relationships between BA ratio,
demographics, lung volume and lung
function
We found no significant associations between the BA
ratio and either age (r = 0.16, P = 0.11) or height
(r = 0.07, P = 0.43). The former result is in contrast
Table 1 Characteristics of the 106 never-smokers
subjects
Characteristic Mean  SD or %
Male gender 32
Age (years) 62  9
Non-Hispanic White race 92
Height (cm) 167  9
FEV1 (L) 2.8  0.7
FEV1 (% predicted) 104  14
FVC (L) 3.6  0.9
FVC (% predicted) 99  12
FEV1/FVC ratio 0.80  0.05
TLCCT (L) 5.4  1.2
TLCCT (% predicted) 97  12
CT, computed tomography; FEV1, forced expiratory volume in
1 s; FVC, forced vital capacity; SD, standard deviation; TLC, total
lung capacity; TLCCT, CT lung volume at maximal inflation.
Figure 1 Bland–Altman plot of bronchoarterial (BA) ratio. The
plot shows the intra-analyst (A) and inter-analyst (B) agreements
of BA ratio from 20 subjects.
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with Matsuoka et al.’s study8 who observed a direct
relationship between age and the BA ratio. There
was no difference in the BA ratio between males and
females (0.82 vs. 0.78, P = 0.26) and between
non-Hispanic Whites and African-Americans (n = 8)
(0.80 vs 0.79, P = 0.91). We did not find statistical dif-
ferences in BA ratio by scanner brands (P = 0.48). In
univariate analysis, the BA ratio was significantly asso-
ciated with FVC (r = 0.20, P = 0.04) and TLCCT
(r = 0.23, P = 0.02), and marginally significantly related
to FEV1 (0.19, P = 0.053). In multivariable models
adjusted for age, gender, race and height, the BA ratio
became significantly associated with FEV1 (Table 3).
Results were comparable for the relationships between
FEV1 and the BA ratio at RB1 and RB10 levels
(Table 3). To understand the relative contributions of
the BA ratio (lumen or vascular diameter) to the rela-
tionship with the FEV1, additional correlative analysis
was performed. The FEV1 was more strongly associated
with mean bronchial lumen diameter (r = 0.43,
P < 0.0001) than with mean pulmonary artery diameter
(r = 0.26, P = 0.006)
DISCUSSION
We examined BA ratios on volumetric CT scans
obtained from 106 never-smokers subjects. We found
that the mean BA ratio was 0.79, varied by bronchial
generations, and was >1 in 10 subjects (8.5%). Subjects
with the ratio >1 had smaller artery diameters but not
significantly larger bronchial lumens than those with a
BA ratio ≤1. Never-smokers subjects with a larger BA
ratio had higher FEV1 in multivariable analysis.
In this study, we found that in never-smokers sub-
jects the BA ratio was directly related to expiratory air-
flow after adjustment for age, gender, race and height.
Assuming that this population represents adults with
native lung structure, this novel finding suggests that
bronchovascular anatomy contributes to expiratory air-
flow regardless of a subject’s size. Our data indicate
that airway lumen and calibre of the adjacent artery
are associated with spirometric measures of lung func-
tion. Furthermore, bronchial lumen size was more
strongly correlated with FEV1 than pulmonary arterial
diameter. These findings support the concept of
Table 2 Bronchoarterial ratio in RB1 ad RB10
Characteristic Mean  SD
RB1 generation*
Fourth 0.86  0.27
Fifth 0.80  0.20
Sixth 0.76  0.23
Mean RB1 0.81  0.20
RB10 generation**
Fourth 0.79  0.15
Fifth 0.79  0.21
Sixth 0.76  0.20
Mean RB10*** 0.78  0.17
Mean RB1 and RB10 0.79  0.16
*P trend = 0.0001 by RB1 generation; **P trend = 0.14 by
RB10 generation; ***P = 0.17 between RB1 and RB10.
RB1, right upper lobe apical bronchus; RB10, right lower lobe
basal posterior bronchus; SD, standard deviation.
Figure 2 Box plots of bronchial and
pulmonary artery diameters in never-
smoker subjects by bronchoarterial (BA)
ratio group. The plot shows the difference
in airway lumen and artery diameters
between those with BA -ratio ≤1 and >1.
Note that the artery diameter is smaller in
never smokers with BA ratio >1 than
those with the ratio ≤1.
Table 3 Multivariable model for FEV1 (in L) using the BA ratio
Variable
Bronchial path
RB1 and RB10 RB1 RB10
BA ratio Estimate (SE) P-value Estimate (SE) P-value Estimate (SE) P-value
BA ratio 0.79 (0.23) 0.0007 0.54 (0.18) 0.003 0.58 (0.22) 0.0108
Age (per 10 years) −0.28 (0.04) <0.0001 −0.25 (0.04) <0.0001 −0.28 (0.04) <0.0001
Male gender 0.67 (0.10) <0.0001 0.69 (0.10) <0.0001 0.65 (0.10) <0.0001
Non-Hispanic White race 0.35 (0.14) 0.01 0.30 (0.14) 0.03 0.38 (0.14) 0.0071
Height (per 10 cm) 0.32 (0.05) <0.0001 0.31 (0.05) <0.0001 0.32 (0.05) <0.0001
BA, bronchoarterial; FEV1, forced expiratory volume in 1 s; RB1, right upper lobe apical bronchus; RB10, right lower lobe basal pos-
terior bronchus; SE, standard error.
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dysanaptic lung development where the bronchial tree
and lung parenchyma develop somewhat independ-
ently.21 This concept has been used to explain the
observed variability in peak expiratory flow independ-
ent of lung size. The FEV1–BA ratio relationship we
observed is also keeping with prior data13 demonstrat-
ing that normal subjects with the larger extra-
parenchymal and intra-parenchymal bronchial lumen
volumes have the higher expiratory flows independent
of body size.
In this cohort, the mean BA ratio was 0.79 with
10 never-smokers subjects having a ratio >1. A novel
finding was that when the ratio was >1 it was due to a
smaller pulmonary artery rather than a larger airway.
We believed that this might have implications in health
and disease. First, normative data on objective mea-
surements of both airway and vessel sizes are needed
to understand their variability and how they relate each
other. In the setting of disease, an increased BA ratio
could imply an abnormality of the airway, vessel or
both, that is we believe an increased BA ratio in disease
might reflect a bronchovascular process rather than a
bronchial abnormality alone. Another implication is
that using vessel size as a reference for airway dilation
might not be appropriate. Additionally, using a fixed
ratio to define disease may also be inappropriate. This
finding expands upon the work of Lynch et al.22 who
documented that a visual BA ratio >1 was present in
36% of 142 bronchi from 27 control subjects. Our
results provide objective support that a BA ratio >1
may not suffice to diagnose bronchiectasis. In locations
where the airways do not typically run orthogonal to
the axial plane (e.g. middle lobe and lingula), other
radiographical features (e.g. lack of airway tapering)
are useful to detect bronchiectasis.
Our mean BA ratio was larger than those ranging
from 0.62 to 0.695 reported in prior CT studies on sub-
jects without pulmonary disease.5–8 A potential expla-
nation for this difference is that our subjects were on
average older. Matsuoka et al.8 documented a BA ratio
of 0.785, which is closer to ours, in ≥65-year-old sub-
jects. Additionally, differences in airway sampling
methods (anatomical-based vs non-anatomical-based
approaches) and populations (age and racial composi-
tion) across studies5–8 may also contribute to these dis-
crepancies. Variability of the BA ratio by RB1 airway
generation was also observed by Kim et al.7 but not in
other studies.5,6 Further research including subjects
with a wide age range and from varied racial groups is
needed to investigate BA ratio variability as well as the
potential clinical implications of this variation.
We did not find differences in BA ratio between gen-
ders, a finding that is in agreement with a prior CT
study.8 There was no difference in this metric between
non-Hispanic Whites and African-Americans. However,
the small sample of African-Americans in our cohort
likely limits the ability to detect significant racial
differences.
This study has several limitations. First, our study
subjects are mainly non-Hispanic White females limit-
ing the generalizability of the current findings. Control
subjects were chosen based on self-reported data and
no medical records were used to verify this condition.
Although we used only one analyst to perform the BA
ratio measurements, our results were consistent with
those reported previously.8 We have used only cross-
sectional data and thus causality of the observed rela-
tionship cannot be elucidated. We only surveyed RB1
and RB10 bronchial paths; however, we were able to
capture variability of this metric between and within
subjects, while ensuring accurate measurements on
both bronchi and vessels. Some of the strengths of this
study are its relative large sample size, use of volumet-
ric CT scans allowing a detailed examination of the
bronchovascular tree and an anatomical-based selec-
tion of bronchi rather than a random airway selection,
which could introduce bias.23
In summary, we have demonstrated that the mean
BA ratio in never-smokers subjects without pulmonary
disease is 0.79 with 8.5% of them having a ratio >1, a
typical threshold for bronchiectasis. Interestingly, sub-
jects with a BA ratio >1 had smaller vessel diameters
but not larger bronchial lumens than those with BA
ratio ≤1. The BA ratio was directly related to expiratory
airflow regardless of body size. Further investigation
with larger samples of healthy individuals is required
to obtain normative data in this defining imaging
metric.
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